USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALLVIVO VASCULAR, INC.
Address:
20914 BAKE PKY
LAKE FOREST, CA
Phone:
N/A
URL:
N/A
EIN:
800103269
DUNS:
179043893
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $197,090.00 2
SBIR Phase II $3,819,338.00 2

Award List:

SBIR/STTR Phase I:Surface Modification to Direct Cell Behavior

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$97,543.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project will develop a surface coating technology that will be used to create improved materials for regulating cell behavior for research, tissue engineering and cell therapy applications. For these applications, advanced materials are needed… More

Peptide Based Antibacterial Coating

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$99,547.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this SBIR Phase I project is to develop antibacterial coatings for medical devices. The use of traditional antimicrobials on devices poses a substantial risk for developing drug resistant bacteria. The objective is to develop coatings… More

Dual Function Catheter to Prevent Thrombus and Infection

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$821,425.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The objective of this work is to develop dual function antibacterial coatings that prevent biofilm formation and thrombus. A key feature of this technology is that it will prevent biofilm formation without an associated risk of creating antibiotic resistant… More

Dual Function Catheter to Prevent Thrombus and Infection

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,997,913.00
Agency:
HHS
Principal Investigator:
Jennifer A. Neff – 949-716-6478
Abstract:
DESCRIPTION (provided by applicant): The objective of this work is to complete development of a novel antibacterial, acute hemodialysis catheter and conduct the preclinical testing required for FDA approval. This product will address 3 major unmet needs for intravenous catheters by: (1) providing… More